The brain ages like the rest of the body. Alzheimer's is a disease.
À medida que a população mundial envelhece, a Organização Mundial da Saúde alerta para uma crise silenciosa que já afeta 55 milhões de pessoas: o Alzheimer, responsável por 70% dos casos de demência, deve triplicar sua incidência até 2050, chegando a 131,5 milhões de vidas transformadas. No Brasil, 1,2 milhão de pessoas convivem com a doença, e 100 mil novos diagnósticos são feitos a cada ano. No Dia Mundial do Alzheimer, a humanidade é convidada a refletir não apenas sobre os avanços científicos — como o novo exame de imagem PET-CT disponível no país —, mas sobre o que significa cuidar de quem, aos poucos, perde a memória de si mesmo.
- A OMS projeta que o número de pessoas com demência quase triplicará até 2050, transformando o Alzheimer em uma das maiores crises de saúde pública do século.
- No Brasil, um novo diagnóstico de Alzheimer é feito a cada cinco minutos, pressionando famílias, sistemas de saúde e redes de cuidado que ainda não estão preparados para essa escala.
- A chegada do exame PET-CT com Florbetabeno-18F ao país representa um avanço real: pela primeira vez, é possível identificar as placas de beta-amiloide no cérebro antes que os sintomas se agravem.
- Médicos e pesquisadores reforçam que diagnóstico precoce abre janelas de tratamento que retardam a perda neuronal e preservam a qualidade de vida por mais tempo.
- Sem cura à vista, a ciência aponta para hábitos de vida — exercício físico, estímulo mental, controle de comorbidades — como as ferramentas mais concretas de prevenção e retardo da doença.
- No centro de tudo, a presença humana permanece a medicina mais essencial: familiares e amigos são, para quem tem Alzheimer, o último e mais duradouro elo com o mundo.
A Organização Mundial da Saúde emitiu um alerta grave: 55 milhões de pessoas vivem hoje com alguma forma de demência no mundo, e sete em cada dez têm Alzheimer. Os números não param de crescer. Pesquisadores da Alzheimer's Disease International estimam que esse total chegará a quase 75 milhões em 2030 e a 131,5 milhões em 2050 — impulsionado pelo envelhecimento inevitável da população global.
O Brasil reflete essa realidade com clareza. São 1,2 milhão de brasileiros com Alzheimer e 100 mil novos casos diagnosticados por ano. No dia 21 de setembro, data marcada como Dia Mundial e Dia Nacional de Conscientização da doença, o país volta os olhos para o que significa conviver com ela — e para o papel insubstituível de familiares e amigos nesse cuidado.
O Alzheimer destrói neurônios responsáveis pela formação de memórias. Os primeiros sinais costumam aparecer na sexta ou sétima década de vida: nomes esquecidos, perguntas repetidas, incapacidade de assimilar informações novas. É fundamental distinguir esse processo do envelhecimento natural — o Alzheimer é uma doença, não uma consequência inevitável do tempo.
Uma novidade chegou ao Brasil com potencial de mudar esse cenário: o exame PET-CT com Florbetabeno-18F, capaz de detectar o acúmulo de placas de beta-amiloide no cérebro — as marcas moleculares da doença — antes que os sintomas se agravem. Quanto mais cedo o diagnóstico, mais cedo começa o tratamento que retarda a morte dos neurônios e preserva a qualidade de vida do paciente.
Sem cura, o que existe são estratégias: manter a mente ativa com leitura, escrita e aprendizado; praticar exercícios físicos regularmente; tratar condições como hipertensão, diabetes e depressão, que aumentam o risco da doença. E, acima de tudo, garantir presença humana — passeios, conversas, estímulos, companhia. Para quem perde a memória aos poucos, o afeto de quem está por perto é, muitas vezes, a última e mais poderosa forma de tratamento disponível.
The World Health Organization has sounded an urgent alarm about a disease that will reshape the lives of hundreds of millions of people over the next three decades. Right now, roughly 55 million people worldwide are living with dementia of some kind. Seven out of every ten of them have Alzheimer's disease—a progressive, incurable condition that slowly erases memory and cognitive function. But the numbers are about to get much worse.
Demographers and disease researchers at Alzheimer's Disease International, based in the United Kingdom, have run the projections. By 2030, they estimate the global count will reach nearly 75 million people. By 2050, it will climb to 131.5 million. The driver is simple and relentless: the world's population is aging. As people live longer, more of them will develop the disease. The WHO's warning reflects a hard truth: this is not a crisis that will resolve itself. It will only deepen.
Brazil offers a window into what this means at the national level. The country's health ministry reports that approximately 1.2 million Brazilians currently have Alzheimer's disease. Every year, doctors diagnose 100,000 new cases. On September 21st—marked globally as World Alzheimer's Day and in Brazil as National Alzheimer's Awareness Day—the focus turns to understanding the disease and the role families and friends must play in caring for those affected.
Alzheimer's works by destroying neurons, the brain cells responsible for forming and storing memories. As these cells die, the patient loses the ability to create new memories. The early signs are often subtle but unmistakable to those closest to the person: forgotten names of grandchildren, the same question asked repeatedly within minutes, an inability to learn new information. These symptoms typically emerge in the sixth or seventh decade of life, though the disease can strike younger people when genetic predisposition is present. A person in their forties with Alzheimer's has likely carried the biological seeds of the disease for decades, waiting for the dysfunction to surface.
It is crucial not to confuse Alzheimer's with normal aging. The brain ages like the rest of the body—that is inevitable and natural. Alzheimer's is a disease, a pathological process distinct from the ordinary wear of time. Understanding this distinction matters because it shapes how we think about prevention and treatment.
Recently, a new diagnostic tool has arrived in Brazil that offers genuine hope for earlier detection. It is called PET-CT with Florbetabeno-18F, a non-invasive imaging test that measures the buildup of beta-amyloid plaques in the brain. These plaques accumulate and interfere with how brain cells function; doctors consider them the fingerprints of Alzheimer's. The test is new to the country and significant because it allows physicians to catch the disease sooner. And timing matters enormously. The earlier a diagnosis is made, the sooner treatment can begin—medication that slows the rate at which neurons die, extending the patient's quality of life and improving their long-term outlook.
But imaging alone is not enough. Neurologists emphasize that the test strengthens clinical suspicion and enables early detection, but it must be paired with careful evaluation of symptoms. Once diagnosed, the focus shifts to slowing progression and maintaining function. There is no cure for Alzheimer's, and no proven way to prevent it entirely. What exists instead is a set of practices that can delay its onset or slow its advance: keeping the mind active through reading, writing, puzzles, and learning; maintaining regular physical exercise; managing related health conditions like high blood pressure, high cholesterol, and diabetes. Recent research has linked Alzheimer's to depression, sleep apnea, smoking, and metabolic disease. Treating these conditions early can reduce the risk that an older person will develop Alzheimer's later.
Family support is not optional—it is foundational. A person with Alzheimer's is not forgetting names because they choose to. They need patience, encouragement, and engagement: trips to museums, theaters, parks, cinema outings, mental stimulation. These activities are not luxuries. They are what keep a person connected to life and to the people around them for as long as possible. As the disease advances inexorably, this human presence becomes the last and most important medicine available.
Citações Notáveis
The person is suffering from an illness. They are not confusing their grandchild's name because they want to. I ask families to support them, stimulate them, take them to museums and theaters, be patient—these activities keep the patient functioning with minimal quality of life to interact with others.— A specialist quoted on the importance of family support
When you occupy the brain, you delay the disease.— A neurologist on mental stimulation and prevention
A Conversa do Hearth Outra perspectiva sobre a história
Why does the WHO think this matters enough to sound an alarm now, in 2022? The disease has always existed.
Because the numbers are about to explode. We're not talking about a stable problem. We're talking about a disease that will affect 131 million people by 2050 if current trends hold. That's a tripling. Healthcare systems, families, entire countries are not prepared for that scale.
But you said there's no cure. So what does early detection actually change?
Everything, in a way. You can't cure it, but you can slow it down. If you catch it early and start medication, the neurons die more slowly. That means years of better memory, better function, better quality of life. For someone in their sixties, that could mean a decade of difference.
The article mentions that keeping your brain active can delay the disease. How much can that actually help?
No one knows exactly. But the evidence is strong enough that neurologists recommend it seriously. Reading, puzzles, learning new things—these aren't guarantees, but they seem to matter. It's one of the few things people can actually control.
What about the family piece? Why is that so important to emphasize on World Alzheimer's Day?
Because the disease doesn't just happen to the patient. It happens to everyone around them. And the patient needs that presence—needs to be taken places, stimulated, treated with patience. Without family support, the person deteriorates faster. It's not sentiment. It's medicine.
So if I'm reading this right, the real crisis isn't just the disease itself. It's that we're not ready for this many people to have it.
Exactly. We have a new imaging tool that can help us diagnose earlier. We know what slows progression. But we don't have enough doctors, enough care infrastructure, enough family resources to handle 131 million people with Alzheimer's. That's the alarm the WHO is sounding.